Contract Manufacturing
Catalent Expands Temperature-Controlled Clinical Supply Capabilities in Shanghai, China
The facility will be expanded by approximately 30,000 square feet (approximately 2,800 square meters), which will double the clinical storage capacity...
February 16, 2022 | News
WuXi STA Wins 2022 CMO Leadership Awards in All Six Core Categories
For the 2022 CMO Leadership Awards, Life Science Leader Magazine teamed up with Industry Standard Research (ISR) to conduct the Contract Manufacturing Qual...
February 11, 2022 | News
Merck to Strengthen CDMO Offering and Accelerate Future Growth
New operating model to accelerate profitable growth strategy Newly formed Life Science Services business unit to offer fully integrated CDMO and Contrac...
February 09, 2022 | News
Samsung Biologics receives 2022 CMO Leadership Award in all six categories
Now in its 11th year, the CMO Leadership Awards offer accurate and reliable customer feedback to provide support in choosing a reputable partner for develo...
February 08, 2022 | News
National Cancer Center Japan and GenScript ProBio Enter Research Collaboration Agreement for a Plasmid & Lentiviral vector CMC development
The project initialized by National Cancer Center Research Institute. Under the agreement, National Cancer Center and GenScript Biotech will collaborate on...
February 07, 2022 | News
CordenPharma Completes Acquisition of Three Manufacturing Facilities from Vifor Pharma
Dr. Michael Quirmbach, Chief Executive Officer & President of CordenPharma said, "We welcome the three sites and their employees as new members to...
February 02, 2022 | News
Biogen to acquire full ownership of Samsung Bioepis
Agreement with Biogen to buyout Biogen's (50% -1 share) stake in Samsung Bioepis Joint Venture for up to USD $2.3 billion Transaction projected to ...
January 28, 2022 | News
GenScript ProBio initiates a CDMO Contract For Next-Generation CD47 Antibody with InnoBation Bio
InnoBation Bio, led by Seung-gu Kim (CEO), is a biopharmaceutical company specializing in the development of biomarkers, Chimeric Antigen Receptor (CAR) T ...
January 26, 2022 | News
Samsung Biologics Reports Fourth Quarter & Fiscal Year 2021 Financial Results
Q4'21 revenue of KRW 444.3 billion increased 18% compared to Q4'20. Q4'21 operating profit of KRW 128.8 billion increased 39% compar...
January 25, 2022 | News
WuXi STA Launches its First Parenteral Formulation Manufacturing Line
The industry-leading automatic parenteral filling line features multiple filling modules and a built-in lyophilizer to fill vials, syringes, and ...
January 24, 2022 | News
GenScript ProBio to Expand Commercial cGMP Plasmid and Viral Vector
On January 19, 2022, GenScript ProBio broke ground for the construction of its newest plasmid and viral vector manufacturing facility, a 34,000-square...
January 21, 2022 | News
Vetter's new clinical manufacturing site now officially authorized
Important milestone reached for the new site Additional filling capacities for early-stage clinical development First customer audits already completed...
January 20, 2022 | News
WuXi Biologics completes the first GMP inspection in 2022
WuXi Biologics a global company with leading open-access biologics technology platforms, announced that it has completed a remote GMP inspection by&n...
January 18, 2022 | News
Piramal Pharma Solutions Strengthens North American Capabilities
The Pharma Solutions (PPS) division of Piramal Enterprises Limited, a leading research, development and contract manufacturing (CDMO) organization, today...
January 14, 2022 | News
Most Read
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
